No Data
Morgan Stanley Cuts STAAR to Underweight, Cites Growth Expectations
Medical Technology Companies Poised for Another 'Solid' Quarter, Morgan Stanley Says
Most medical technology companies appear well positioned as they prepare to report their Q2 financial results, analysts at Morgan Stanley said Monday, citing recent discussions with the companies
Staar Surgical Is Maintained at Buy by BTIG
Staar Surgical Is Maintained at Buy by
Staar Surgical Price Target Raised to $53.00/Share From $46.00 by BTIG
Staar Surgical Price Target Raised to $53.00/Share From $46.00 by
Expert Outlook: Staar Surgical Through The Eyes Of 5 Analysts
Staar Surgical (NASDAQ:STAA) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.Summarizing their recent assessments, the
Express News | STAAR Surgical Shares Slip 4.8% Premarket After Morgan Stanley Cuts to Underweight